Bio Lab Naturals to acquire Limitless X in reverse merger; LXI shareholders to own ~90% of combined entity

Limitless X Holdings Inc.

Bio Lab Naturals will acquire all of Limitless X (health/wellness, beauty, CBD) via share exchange.
LXI shareholders receive 97M BLAB common shares (plus 9M shares in 6 months), owning ~90% of combined company.
LXI CEO to purchase 500K shares of BLAB Series A Preferred Stock with super voting rights (60% votes), effecting change in control.
Closing targeted for May 20, 2022; transaction subject to customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.